Literature DB >> 11063617

Inhibition of protein synthesis by didemnins: cell potency and SAR.

D Ahuja1, A Geiger, J M Ramanjulu, M D Vera, B SirDeshpande, A Pfizenmayer, M Abazeed, D J Krosky, D Beidler, M M Joullié, P L Toogood.   

Abstract

Synthetic and naturally occurring didemnins are potent and specific inhibitors of protein synthesis in vitro. Structure-activity analysis indicates a requirement for the intact macrocycle; however, the smaller ring size represented by the didemnin analogue, tamandarin A, is equipotent to didemnin B. Replacement of the N,O-dimethyltyrosine by a N-methylphenylalanine or N-methylleucine residue is also well-tolerated. The rank order for inhibition of protein synthesis in vitro appears to be retained in MCF-7 cells, albeit at much higher potency. This increase in potency is explained for the first time by data indicating that MCF-7 cells can accumulate didemnin B up to 2-3 orders of magnitude compared to the growth medium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063617     DOI: 10.1021/jm000168v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Synthetic studies of tamandarin B side chain analogues.

Authors:  Kenneth M Lassen; Jisun Lee; Madeleine M Joullié
Journal:  J Org Chem       Date:  2010-05-07       Impact factor: 4.354

2.  Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis.

Authors:  Francis Robert; Hong Qing Gao; Marwa Donia; William C Merrick; Mark T Hamann; Jerry Pelletier
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

Review 3.  Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.

Authors:  Guadalupe-Miroslava Suarez-Jimenez; Armando Burgos-Hernandez; Josafat-Marina Ezquerra-Brauer
Journal:  Mar Drugs       Date:  2012-04-26       Impact factor: 6.085

4.  The Effects of Purified Artemia Extract Proteins on Proliferation, Differentiation and Apoptosis of Human Leukemic HL-60 Cells

Authors:  Abdolkhaleg Deezagi; Azadeh Chashnidel; Neda Vaseli Hagh; Mahvash Khodabandeh Shahraki
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

5.  Imminent Angiotensin-converting Enzyme Inhibitor from Microbial Source for Cancer Therapy.

Authors:  Lida Ebrahimi; Jafar Ai; Aliakbar Alizadeh; Mehrdad Shariaty
Journal:  Int J Prev Med       Date:  2017-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.